John Heath
John Heath
Verified email at bham.ac.uk
Title
Cited by
Cited by
Year
Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides
AG Smith, JK Heath, DD Donaldson, GG Wong, J Moreau, M Stahl, ...
nature 336 (6200), 688-690, 1988
22581988
Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor.
DR Edwards, G Murphy, JJ Reynolds, SE Whitham, AJ Docherty, P Angel, ...
The EMBO journal 6 (7), 1899-1904, 1987
13801987
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A 2a receptor
C Ledent, JM Vaugeois, SN Schiffmann, T Pedrazzini, M El Yacoubi, ...
Nature 388 (6643), 674-678, 1997
9851997
Mesoderm induction in early Xenopus embryos by heparin-binding growth factors
JMW Slack, BG Darlington, JK Heath, SF Godsave
Nature 326 (6109), 197-200, 1987
9631987
PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis
H Boström, K Willetts, M Pekny, P Levéen, P Lindahl, H Hedstrand, ...
Cell 85 (6), 863-873, 1996
8701996
Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development
E Arman, R Haffner-Krausz, Y Chen, JK Heath, P Lonai
Proceedings of the National Academy of Sciences 95 (9), 5082-5087, 1998
6591998
Fibroblast growth factors induce additional limb development from the flank of chick embryos
MJ Cohn, JC Izpisúa-Belmonte, H Abud, JK Heath, C Tickle
Cell 80 (5), 739-746, 1995
6321995
Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization
S Nomura, AJ Wills, DR Edwards, JK Heath, BL Hogan
The Journal of cell biology 106 (2), 441-450, 1988
5731988
Oligodendrocyte population dynamics and the role of PDGF in vivo
AR Calver, AC Hall, WP Yu, FS Walsh, JK Heath, C Betsholtz, ...
Neuron 20 (5), 869-882, 1998
5141998
Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice
M Fruttiger, L Karlsson, AC Hall, A Abramsson, AR Calver, H Bostrom, ...
Development 126 (3), 457-467, 1999
4791999
Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways
KC Wollert, T Taga, M Saito, M Narazaki, T Kishimoto, CC Glembotski, ...
Journal of Biological Chemistry 271 (16), 9535-9545, 1996
4451996
Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development
P Lindahl, L Karlsson, M Hellstrom, S Gebre-Medhin, K Willetts, JK Heath, ...
Development 124 (20), 3943-3953, 1997
3981997
Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage
PD Rathjen, S Toth, A Willis, JK Heath, AG Smith
Cell 62 (6), 1105-1114, 1990
3131990
Abnormal gastrointestinal development in PDGF-A and PDGFR-(alpha) deficient mice implicates a novel mesenchymal structure with putative instructive properties in villus …
L Karlsson, P Lindahl, JK Heath, C Betsholtz
Development 127 (16), 3457-3466, 2000
2962000
Functions of fibroblast growth factors and their receptors
AOM Wilkie, GM Morriss-Kay, EY Jones, JK Heath
Current Biology 5 (5), 500-507, 1995
2931995
Receptor recognition by gp130 cytokines
J Bravo, JK Heath
The EMBO journal 19 (11), 2399-2411, 2000
2732000
Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity
NS Chang, N Pratt, J Heath, L Schultz, D Sleve, GB Carey, N Zevotek
Journal of Biological Chemistry 276 (5), 3361-3370, 2001
2582001
Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand
J Anderson, HD Burns, P Enriquez-Harris, AOM Wilkie, JK Heath
Human molecular genetics 7 (9), 1475-1483, 1998
2541998
The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding
RC Robinson, LM Grey, D Staunton, H Vankelecom, AB Vernallis, ...
Cell 77 (7), 1101-1116, 1994
2511994
Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2
S Iseki, AO Wilkie, JK Heath, T Ishimaru, K Eto, GM Morriss-Kay
Development 124 (17), 3375-3384, 1997
2221997
The system can't perform the operation now. Try again later.
Articles 1–20